Literature DB >> 9582268

Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain.

M G Mateu1, A R Fersht.   

Abstract

The contribution of almost each amino acid side chain to the thermodynamic stability of the tetramerization domain (residues 326-353) of human p53 has been quantitated using 25 mutants with single-residue truncations to alanine (or glycine). Truncation of either Leu344 or Leu348 buried at the tetramer interface, but not of any other residue, led to the formation of dimers of moderate stability (8-9 kcal/mol of dimer) instead of tetramers. One-third of the substitutions were moderately destabilizing (<3.9 kcal/mol of tetramer). Truncations of Arg333, Asn345 or Glu349 involved in intermonomer hydrogen bonds, Ala347 at the tetramer interface or Thr329 were more destabilizing (4.1-5.7 kcal/mol). Strongly destabilizing (8.8- 11.7 kcal/mol) substitutions included those of Met340 at the tetramer interface and Phe328, Arg337 and Phe338 involved peripherally in the hydrophobic core. Truncation of any of the three residues involved centrally in the hydrophobic core of each primary dimer either prevented folding (Ile332) or allowed folding only at high protein concentration or low temperature (Leu330 and Phe341). Nine hydrophobic residues per monomer constitute critical determinants for the stability and oligomerization status of this p53 domain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9582268      PMCID: PMC1170615          DOI: 10.1093/emboj/17.10.2748

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.

Authors:  H W Stürzbecher; R Brain; C Addison; K Rudge; M Remm; M Grimaldi; E Keenan; J R Jenkins
Journal:  Oncogene       Date:  1992-08       Impact factor: 9.867

2.  Definition of a consensus binding site for p53.

Authors:  W S el-Deiry; S E Kern; J A Pietenpol; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

3.  Effect of cavity-creating mutations in the hydrophobic core of chymotrypsin inhibitor 2.

Authors:  S E Jackson; M Moracci; N elMasry; C M Johnson; A R Fersht
Journal:  Biochemistry       Date:  1993-10-26       Impact factor: 3.162

4.  Structure of the transition state for the folding/unfolding of the barley chymotrypsin inhibitor 2 and its implications for mechanisms of protein folding.

Authors:  D E Otzen; L S Itzhaki; N F elMasry; S E Jackson; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

5.  p53 domains: structure, oligomerization, and transformation.

Authors:  P Wang; M Reed; Y Wang; G Mayr; J E Stenger; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

6.  High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.

Authors:  G M Clore; J G Omichinski; K Sakaguchi; N Zambrano; H Sakamoto; E Appella; A M Gronenborn
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

7.  Contributions of the polar, uncharged amino acids to the stability of staphylococcal nuclease: evidence for mutational effects on the free energy of the denatured state.

Authors:  S M Green; A K Meeker; D Shortle
Journal:  Biochemistry       Date:  1992-06-30       Impact factor: 3.162

8.  The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.

Authors:  N P Pavletich; K A Chambers; C O Pabo
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

9.  Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution.

Authors:  H Sakamoto; M S Lewis; H Kodama; E Appella; K Sakaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding.

Authors:  J L Waterman; J L Shenk; T D Halazonetis
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  41 in total

1.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Mutually compensatory mutations during evolution of the tetramerization domain of tumor suppressor p53 lead to impaired hetero-oligomerization.

Authors:  M G Mateu; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Equilibrium unfolding studies of the rat liver methionine adenosyltransferase III, a dimeric enzyme with intersubunit active sites.

Authors:  María Gasset; Carlos Alfonso; José L Neira; Germán Rivas; María A Pajares
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

4.  Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.

Authors:  Jayne M Stommel; Geoffrey M Wahl
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

5.  Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid.

Authors:  Juan Reguera; Aura Carreira; Laura Riolobos; José María Almendral; Mauricio G Mateu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

6.  Planck-Benzinger thermal work function: thermodynamic characterization of the carboxy-terminus of p53 peptide fragments.

Authors:  Paul W Chun; Marc S Lewis
Journal:  Protein J       Date:  2010-11       Impact factor: 2.371

7.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.

Authors:  Maria Rosario Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

8.  Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.

Authors:  Rui Kamada; Takao Nomura; Carl W Anderson; Kazuyasu Sakaguchi
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

9.  The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter site.

Authors:  Maria M García-Alai; Henning Tidow; Eviatar Natan; Fiona M Townsley; Dmitry B Veprintsev; Alan R Fersht
Journal:  Protein Sci       Date:  2008-07-11       Impact factor: 6.725

10.  Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers.

Authors:  Jan van Dieck; Maria R Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.